Author:
Dalton James T.,Taylor Ryan P.,Mohler Michael L.,Steiner Mitchell S.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Critical Care and Intensive Care Medicine,Oncology (nursing),Oncology,General Medicine
Reference6 articles.
1. An overview of selective androgen receptor modulators: focus on enobosarm.;Jones;Drugs of the Future,2013
2. The safety, pharmacokinetics, and effects of LGD-4033, a novel nonsteroidal oral, selective androgen receptor modulator, in healthy young men.;Basaria;J Gerontol A Biol Sci Med Sci,2013
3. A phase IIa randomized, placebo-controlled clinical trial to study the efficacy and safety of the selective androgen receptor modulator (SARM) MK-0773 in female participants with sarcopenia.;Papanicolaou;J Nutr Health Aging,2013
4. A 12-week pharmacokinetic and pharmacodynamic study of two selective androgen receptor Modulators (SARMs) in postmenopausal subjects (Abstract P2-2).;Marcantonio;Endocr Rev,2010
5. Effects of enobosarm on muscle wasting and physical function in patients with cancer: a double-blind, randomized controlled phase 2 trial.;Dobs;Lancet Oncol,2013
Cited by
71 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献